Regulation of EMT by TGFβ in cancer

FEBS Letters

Volumn 586, Issue 14, 2012, Pages 1959-1970

  Heldin, Carl Henrik ^a   Vanlandewijck, Michael ^a   Moustakas, Aristidis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; MAPK; Metastasis; Smad; TGF

Indexed keywords

ANTIMETASTATIC AGENT; HIGH MOBILITY GROUP A2 PROTEIN; LY 2109761; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; NUCLEIC ACID BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN ZEB1; PROTEIN ZEB2; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; BONE METASTASIS; CANCER INVASION; CANCER MODEL; CELL ADHESION; CELL FUNCTION; CELL LOSS; CELL POLARITY; DRUG EFFICACY; DRUG USE; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL MOUSE; GENE FUNCTION; HUMAN; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; TUMOR MICROENVIRONMENT;

ANIMALS; CELL ADHESION; CELL NUCLEUS; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; PLATELET-DERIVED GROWTH FACTOR; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA SPLICING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862770017     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.02.037     Document Type: Review

References (140)

1. A. Moustakas, and C.-H. Heldin The regulation of TGFβ signal transduction Development 136 2009 3699 3714
2. J. Massagué TGFβ in cancer Cell 134 2008 215 230
3. K.J. Gordon, and G.C. Blobe Role of transforming growth factor-β superfamily signaling pathways in human disease Biochim. Biophys. Acta 1782 2008 197 228
4. L. Levy, and C.S. Hill Alterations in components of the TGF-β superfamily signaling pathways in human cancer Cytokine Growth Factor Rev. 17 2006 41 58
5. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
6. J.S. Kang, C. Liu, and R. Derynck New regulatory mechanisms of TGF-β receptor function Trends Cell Biol. 19 2009 385 394
7. A. Sorrentino, N. Thakur, S. Grimsby, A. Marcusson, V. von Bulow, N. Schuster, S. Zhang, C.-H. Heldin, and M. Landström The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner Nat. Cell Biol. 10 2008 1199 1207
8. M. Yamashita, K. Fatyol, C. Jin, X. Wang, Z. Liu, and Y.E. Zhang TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β Mol. Cell 31 2008 918 924
9. Y. Mu, R. Sundar, N. Thakur, M. Ekman, S.K. Gudey, M. Yakymovych, A. Hermansson, H. Dimitriou, M.T. Bengoechea-Alonso, J. Ericsson, C.-H. Heldin, and M. Landström TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer Nat. Commun. 2 2011 330
10. P.J. Miettinen, R. Ebner, A.R. Lopez, and R. Derynck TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors J. Cell Biol. 127 1994 2021 2036
11. J.M. López-Novoa, and M.A. Nieto Inflammation and EMT: an alliance towards organ fibrosis and cancer progression EMBO Mol. Med. 1 2009 303 314
12. M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson Evidence that fibroblasts derive from epithelium during tissue fibrosis J. Clin. Invest. 110 2002 341 350
13. M. Zeisberg, C. Yang, M. Martino, M.B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J. Biol. Chem. 282 2007 23337 23347
14. K.K. Kim, M.C. Kugler, P.J. Wolters, L. Robillard, M.G. Galvez, A.N. Brumwell, D. Sheppard, and H.A. Chapman Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix Proc. Natl. Acad. Sci. USA 103 2006 13180 13185
15. E.M. Zeisberg, O. Tarnavski, M. Zeisberg, A.L. Dorfman, J.R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W.T. Pu, A.B. Roberts, E.G. Neilson, M.H. Sayegh, S. Izumo, and R. Kalluri Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat. Med. 13 2007 952 961
16. E.M. Zeisberg, S.E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J. Am. Soc. Nephrol. 19 2008 2282 2287
17. O. Schmalhofer, S. Brabletz, and T. Brabletz E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer Cancer Metastasis Rev. 28 2009 151 166
18. A. Wicki, F. Lehembre, N. Wick, B. Hantusch, D. Kerjaschki, and G. Christofori Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 2006 261 272
19. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7 2007 415 428
20. S.A. Mani, J. Yang, M. Brooks, G. Schwaninger, A. Zhou, N. Miura, J.L. Kutok, K. Hartwell, A.L. Richardson, and R.A. Weinberg Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Proc. Natl. Acad. Sci. USA 104 2007 10069 10074
21. S. Thuault, U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A. Moustakas Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition J. Cell Biol. 174 2006 175 183
22. S. Thuault, E.-J. Tan, H. Peinado, A. Cano, C.-H. Heldin, and A. Moustakas HMGA2 and Smads coregulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition J. Biol. Chem. 283 2008 33437 33446
23. M.A. Smit, T.R. Geiger, J.Y. Song, I. Gitelman, and D.S. Peeper A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis Mol. Cell. Biol. 29 2009 3722 3737
24. N. Dave, S. Guaita-Esteruelas, S. Gutarra, A. Frias, M. Beltran, S. Peiro, and A.G. de Herreros Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition J. Biol. Chem. 286 2011 12024 12032
25. S. Guaita, I. Puig, C. Franci, M. Garrido, D. Dominguez, E. Batlle, E. Sancho, S. Dedhar, A.G. de Herreros, and J. Baulida Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression J. Biol. Chem. 277 2002 39209 39216
26. E. Casas, J. Kim, A. Bendesky, L. Ohno-Machado, C.J. Wolfe, and J. Yang Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis Cancer Res. 71 2011 245 254
27. M. Deckers, M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, and P. ten Dijke The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells Cancer Res. 66 2006 2202 2209
28. U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial mesenchymal cell transition Mol. Biol. Cell 16 2005 1987 2002
29. A.B. Roberts, F. Tian, S.D. Byfield, C. Stuelten, A. Ooshima, S. Saika, and K.C. Flanders Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis Cytokine Growth Factor Rev. 17 2006 19 27
30. E. Piek, A. Moustakas, A. Kurisaki, C.-H. Heldin, and P. ten Dijke TGF-β type I receptor/ALK5 and SMAD proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells J. Cell Sci. 112 1999 4557 4568
31. K.E. Hoot, J. Lighthall, G. Han, S.L. Lu, A. Li, W. Ju, M. Kulesz-Martin, E. Bottinger, and X.J. Wang Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression J. Clin. Invest. 118 2008 2722 2732
32. C.E. Runyan, T. Hayashida, S. Hubchak, J.F. Curley, and H.W. Schnaper Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype J. Biol. Chem. 284 2009 25181 25189
33. S.M. Soond, and A. Chantry Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT Oncogene 30 2011 2451 2462
34. S. Dupont, A. Mamidi, M. Cordenonsi, M. Montagner, L. Zacchigna, M. Adorno, G. Martello, M.J. Stinchfield, S. Soligo, L. Morsut, M. Inui, S. Moro, N. Modena, F. Argenton, S.J. Newfeld, and S. Piccolo FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination Cell 136 2009 123 135
35. W. He, D.C. Dorn, H. Erdjument-Bromage, P. Tempst, M.A. Moore, and J. Massagué Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway Cell 125 2006 929 941
36. C. Hesling, L. Fattet, G. Teyre, D. Jury, P. Gonzalo, J. Lopez, C. Vanbelle, A.P. Morel, G. Gillet, I. Mikaelian, and R. Rimokh Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells EMBO Rep. 12 2011 665 672
37. Tan, E.-J., Thuault, S., Caja, L., Carletti, T., Heldin, C.-H., and Moustakas, A. (in press). Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. J. Biol. Chem.
38. H. Peinado, M. Quintanilla, and A. Cano Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions J. Biol. Chem. 278 2003 21113 21123
39. X. Yin, C.C. Wolford, Y.S. Chang, S.J. McConoughey, S.A. Ramsey, A. Aderem, and T. Hai ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells J. Cell Sci. 123 2010 3558 3565
40. M.A. Huber, N. Azoitei, B. Baumann, S. Grunert, A. Sommer, H. Pehamberger, N. Kraut, H. Beug, and T. Wirth NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J. Clin. Invest. 114 2004 569 581
41. P. Papageorgis, A.W. Lambert, S. Ozturk, F. Gao, H. Pan, U. Manne, Y.O. Alekseyev, A. Thiagalingam, H.M. Abdolmaleky, M. Lenburg, and S. Thiagalingam Smad signaling is required to maintain epigenetic silencing during breast cancer progression Cancer Res. 70 2010 968 978
42. O.G. McDonald, H. Wu, W. Timp, A. Doi, and A.P. Feinberg Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition Nat. Struct. Mol. Biol. 18 2011 867 874
43. M.Z. Wu, Y.P. Tsai, M.H. Yang, C.H. Huang, S.Y. Chang, C.C. Chang, S.C. Teng, and K.J. Wu Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition Mol. Cell 43 2011 811 822
44. B. Shan, T.P. Yao, H.T. Nguyen, Y. Zhuo, D.R. Levy, R.C. Klingsberg, H. Tao, M.L. Palmer, K.N. Holder, and J.A. Lasky Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition J. Biol. Chem. 283 2008 21065 21073
45. X. Wang, J. Nie, Q. Zhou, W. Liu, F. Zhu, W. Chen, H. Mao, N. Luo, X. Dong, and X. Yu Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-β during the process of epithelial to mesenchymal transition in rat proximal epithelial cells Biochim. Biophys. Acta 1782 2008 51 59
46. B. Ozdamar, R. Bose, M. Barrios-Rodiles, H.R. Wang, Y. Zhang, and J.L. Wrana Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity Science 307 2005 1603 1609
47. S. Spaderna, O. Schmalhofer, M. Wahlbuhl, A. Dimmler, K. Bauer, A. Sultan, F. Hlubek, A. Jung, D. Strand, A. Eger, T. Kirchner, J. Behrens, and T. Brabletz The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer Cancer Res. 68 2008 537 544
48. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep. 9 2008 582 589
49. P.A. Gregory, A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, and G.J. Goodall The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat. Cell Biol. 10 2008 593 601
50. M. Korpal, E.S. Lee, G. Hu, and Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J. Biol. Chem. 283 2008 14910 14914
51. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev. 22 2008 894 907
52. Iliopoulos, D., Polytarchou, C., Hatziapostolou, M., Kottakis, F., Maroulakou, I.G., Struhl, K., and Tsichlis, P.N. (2009). MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci. Signal. 2, ra62.
53. M. Beltran, I. Puig, C. Pena, J.M. Garcia, A.B. Alvarez, R. Pena, F. Bonilla, and A.G. de Herreros A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition Genes Dev. 22 2008 756 769
54. P.A. Gregory, C.P. Bracken, E. Smith, A.G. Bert, J.A. Wright, S. Roslan, M. Morris, L. Wyatt, G. Farshid, Y.Y. Lim, G.J. Lindeman, M.F. Shannon, P.A. Drew, Y. Khew-Goodall, and G.J. Goodall An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition Mol. Biol. Cell 22 2011 1686 1698
55. G. Eades, Y. Yao, M. Yang, Y. Zhang, S. Chumsri, and Q. Zhou MiR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells J. Biol. Chem. 286 2011 25992 26002
56. W. Kong, H. Yang, L. He, J.J. Zhao, D. Coppola, W.S. Dalton, and J.Q. Cheng MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mol. Cell. Biol. 28 2008 6773 6784
57. Q. Zhou, J. Fan, X. Ding, W. Peng, X. Yu, Y. Chen, and J. Nie TGF-β-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells J. Biol. Chem. 285 2010 40019 40027
58. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
59. T. Shirakihara, K. Horiguchi, K. Miyazawa, S. Ehata, T. Shibata, I. Morita, K. Miyazono, and M. Saitoh TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition EMBO J. 30 2011 783 795
60. Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi, A., Miyazawa, K., Miyazono, K., and Saitoh, M. (in press). TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene.
61. C.C. Warzecha, T.K. Sato, B. Nabet, J.B. Hogenesch, and R.P. Carstens ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing Mol. Cell 33 2009 591 601
62. C.C. Warzecha, S. Shen, Y. Xing, and R.P. Carstens The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events RNA Biol. 6 2009 546 562
63. A. Chaudhury, G.S. Hussey, P.S. Ray, G. Jin, P.L. Fox, and P.H. Howe TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI Nat. Cell Biol. 12 2010 286 293
64. G.S. Hussey, A. Chaudhury, A.E. Dawson, D.J. Lindner, C.R. Knudsen, M.C. Wilce, W.C. Merrick, and P.H. Howe Identification of an mRNP complex regulating tumorigenesis at the translational elongation step Mol. Cell 41 2011 419 431
65. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr. Opin. Cell Biol. 17 2005 548 558
66. J.I. Yook, X.Y. Li, I. Ota, C. Hu, H.S. Kim, N.H. Kim, S.Y. Cha, J.K. Ryu, Y.J. Choi, J. Kim, E.R. Fearon, and S.J. Weiss A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells Nat. Cell Biol. 8 2006 1398 1406
67. A. Nawshad, D. Medici, C.C. Liu, and E.D. Hay TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex J. Cell Sci. 120 2007 1646 1653
68. T. Vincent, E.P.A. Neve, J.R. Johnson, A. Kukalev, F. Rojo, J. Albanell, K. Pietras, I. Virtanen, L. Philipson, P.L. Leopold, R.G. Crystal, A.G. de Herreros, A. Moustakas, R.F. Pettersson, and J. Fuxe A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition Nat. Cell Biol. 11 2009 943 950
69. K.K. Kim, Y. Wei, C. Szekeres, M.C. Kugler, P.J. Wolters, M.L. Hill, J.A. Frank, A.N. Brumwell, S.E. Wheeler, J.A. Kreidberg, and H.A. Chapman Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis J. Clin. Invest. 119 2009 213 224
70. Zhou, B., Liu, Y., Kahn, M., Ann, D.K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M.S., Liebler, J.M., Minoo, P., Crandall, E.D., and Borok, Z. (in press). β-catenin/CBP-dependent regulation of TGF-β-mediated epithelial-mesenchymal transition (EMT) by smad3. J. Biol. Chem.
71. S. Ripka, A. Konig, M. Buchholz, M. Wagner, B. Sipos, G. Kloppel, J. Downward, T. Gress, and P. Michl WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer Carcinogenesis 28 2007 1178 1187
72. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinberg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 2011 926 940
73. A. Moustakas, and C.-H. Heldin Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression Cancer Sci. 98 2007 1512 1520
74. L.A. Timmerman, J. Grego-Bessa, A. Raya, E. Bertran, J.M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J.C. Izpisua-Belmonte, and J.L. de la Pompa Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation Genes Dev. 18 2004 99 115
75. K. Niessen, Y. Fu, L. Chang, P.A. Hoodless, D. McFadden, and A. Karsan Slug is a direct Notch target required for initiation of cardiac cushion cellularization J. Cell Biol. 182 2008 315 325
76. L. Luna-Zurita, B. Prados, J. Grego-Bessa, G. Luxan, G. del Monte, A. Benguria, R.H. Adams, J.M. Perez-Pomares, and J.L. de la Pompa Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation J. Clin. Invest. 120 2010 3493 3507
77. H. Niimi, K. Pardali, M. Vanlandewijck, C.-H. Heldin, and A. Moustakas Notch signaling is necessary for epithelial growth arrest by TGF-β J. Cell Biol. 176 2007 695 707
78. K.C. Nyhan, N. Faherty, G. Murray, L.B. Cooey, C. Godson, J.K. Crean, and D.P. Brazil Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells Biochim. Biophys. Acta 1803 2010 1386 1395
79. J. Zavadil, L. Cermak, N. Soto-Nieves, and E.P. Bottinger Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition EMBO J. 23 2004 1155 1165
80. J. Sjölund, A.-K. Boström, D. Lindgren, S. Manna, A. Moustakas, B. Ljungberg, M. Johansson, E. Fredlund, and H. Axelson The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma PLoS ONE 6 2011 e23057
81. K. Aoyagi-Ikeda, T. Maeno, H. Matsui, M. Ueno, K. Hara, Y. Aoki, F. Aoki, T. Shimizu, H. Doi, K. Kawai-Kowase, T. Iso, T. Suga, M. Arai, and M. Kurabayashi Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-β-Smad3 pathway Am. J. Respir. Cell Mol. Biol. 45 2011 136 144
82. S. Ohashi, M. Natsuizaka, S. Naganuma, S. Kagawa, S. Kimura, H. Itoh, R.A. Kalman, M. Nakagawa, D.S. Darling, D. Basu, P.A. Gimotty, A.J. Klein-Szanto, J.A. Diehl, M. Herlyn, and H. Nakagawa A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors Cancer Res. 71 2011 6836 6847
83. J. Gotzmann, A.N. Fischer, M. Zojer, M. Mikula, V. Proell, H. Huber, M. Jechlinger, T. Waerner, A. Weith, H. Beug, and W. Mikulits A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes Oncogene 25 2006 3170 3185
84. A.N. Fischer, E. Fuchs, M. Mikula, H. Huber, H. Beug, and W. Mikulits PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression Oncogene 26 2007 3395 3405
85. F. van Zijl, M. Mair, A. Csiszar, D. Schneller, G. Zulehner, H. Huber, R. Eferl, H. Beug, H. Dolznig, and W. Mikulits Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge Oncogene 28 2009 4022 4033
86. C. Lahsnig, M. Mikula, M. Petz, G. Zulehner, D. Schneller, F. van Zijl, H. Huber, A. Csiszar, H. Beug, and W. Mikulits ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression Oncogene 28 2009 638 650
87. M. Jechlinger, A. Sommer, R. Moriggl, P. Seither, N. Kraut, P. Capodiecci, M. Donovan, C. Cordon-Cardo, H. Beug, and S. Grunert Autocrine PDGFR signaling promotes mammary cancer metastasis J. Clin. Invest. 116 2006 1561 1570
88. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
89. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
90. A.P. Morel, M. Lievre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS ONE 3 2008 e2888
91. V.L. Battula, K.W. Evans, B.G. Hollier, Y. Shi, F.C. Marini, A. Ayyanan, R.Y. Wang, C. Brisken, R. Guerra, M. Andreeff, and S.A. Mani Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells Stem Cells 28 2010 1435 1445
92. L. Caja, E. Bertran, J. Campbell, N. Fausto, and I. Fabregat The transforming growth factor-β (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells J. Cell. Physiol. 226 2011 1214 1223
93. M.K. Asiedu, J.N. Ingle, M.D. Behrens, D.C. Radisky, and K.L. Knutson TGFβ/TNF(α)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype Cancer Res. 71 2011 4707 4719
94. R. Li, J. Liang, S. Ni, T. Zhou, X. Qing, H. Li, W. He, J. Chen, F. Li, Q. Zhuang, B. Qin, J. Xu, W. Li, J. Yang, Y. Gan, D. Qin, S. Feng, H. Song, D. Yang, B. Zhang, L. Zeng, L. Lai, M.A. Esteban, and D. Pei A mesenchymal-to- epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts Cell Stem Cell 7 2010 51 63
95. D.X. Nguyen, P.D. Bos, and J. Massagué Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 9 2009 274 284
96. B. Bierie, and H.L. Moses Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer Nat. Rev. Cancer 6 2006 506 520
97. K. Pietras, and A. Östman Hallmarks of cancer: interactions with the tumor stroma Exp. Cell Res. 316 2010 1324 1331
98. D. Pierce Jr., M.D. Johnson, Y. Matsui, S.D. Robinson, L.I. Gold, A.F. Purchio, C.W. Daniel, B. Hogan, and H.L. Moses Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1 Genes Dev. 7 1993 2308 2317
99. R.S. Muraoka, Y. Koh, L.R. Roebuck, M.E. Sanders, D. Brantley-Sieders, A.E. Gorska, H.L. Moses, and C.L. Arteaga Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor β1 Mol. Cell. Biol. 23 2003 8691 8703
100. R.S. Muraoka-Cook, H. Kurokawa, Y. Koh, J.T. Forbes, L.R. Roebuck, M.H. Barcellos-Hoff, S.E. Moody, L.A. Chodosh, and C.L. Arteaga Conditional overexpression of active transforming growth factor β1 in vivo accelerates metastases of transgenic mammary tumors Cancer Res. 64 2004 9002 9011
101. P.M. Siegel, W. Shu, R.D. Cardiff, W.J. Muller, and J. Massagué Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc. Natl. Acad. Sci. USA 100 2003 8430 8435
102. E. Forrester, A. Chytil, B. Bierie, M. Aakre, A.E. Gorska, A.R. Sharif-Afshar, W.J. Muller, and H.L. Moses Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis Cancer Res. 65 2005 2296 2302
103. W. Cui, D.J. Fowlis, S. Bryson, E. Duffie, H. Ireland, A. Balmain, and R.J. Akhurst TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice Cell 86 1996 531 542
104. B.H. Weeks, W. He, K.L. Olson, and X.J. Wang Inducible expression of transforming growth factor β1 in papillomas causes rapid metastasis Cancer Res. 61 2001 7435 7443
105. G. Han, S.L. Lu, A.G. Li, W. He, C.L. Corless, M. Kulesz-Martin, and X.J. Wang Distinct mechanisms of TGF-β1-mediated epithelial-to mesenchymal transition and metastasis during skin carcinogenesis J. Clin. Invest. 115 2005 1714 1723
106. C. Amendt, P. Schirmacher, H. Weber, and M. Blessing Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development Oncogene 17 1998 25 34
107. S.L. Lu, H. Herrington, D. Reh, S. Weber, S. Bornstein, D. Wang, A.G. Li, C.F. Tang, Y. Siddiqui, J. Nord, P. Andersen, C.L. Corless, and X.J. Wang Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma Genes Dev. 20 2006 1331 1342
108. G. Guasch, M. Schober, H.A. Pasolli, E.B. Conn, L. Polak, and E. Fuchs Loss of TGFβ signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia Cancer Cell 12 2007 313 327
109. N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, and H.L. Moses TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 2004 848 851
110. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Met, metastasis, motility and more Nat. Rev. Mol. Cell Biol. 4 2003 915 925
111. N. Cheng, A. Chytil, Y. Shyr, A. Joly, and H.L. Moses Enhanced hepatocyte growth factor signaling by type II transforming growth factor-β receptor knockout fibroblasts promotes mammary tumorigenesis Cancer Res. 67 2007 4869 4877
112. L. Yang, J. Huang, X. Ren, A.E. Gorska, A. Chytil, M. Aakre, D.P. Carbone, L.M. Matrisian, A. Richmond, P.C. Lin, and H.L. Moses Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis Cancer Cell 13 2008 23 35
113. B. Bierie, D.G. Stover, T.W. Abel, A. Chytil, A.E. Gorska, M. Aakre, E. Forrester, L. Yang, K.U. Wagner, and H.L. Moses Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment Cancer Res. 68 2008 1809 1819
114. B. Bierie, C.H. Chung, J.S. Parker, D.G. Stover, N. Cheng, A. Chytil, M. Aakre, Y. Shyr, and H.L. Moses Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer J. Clin. Invest. 119 2009 1571 1582
115. M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells Genes Dev. 10 1996 2462 2477
116. M. Oft, K.H. Heider, and H. Beug TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis Curr. Biol. 8 1998 1243 1252
117. E. Janda, K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grunert Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways J. Cell Biol. 156 2002 299 313
118. T. Waerner, M. Alacakaptan, I. Tamir, R. Oberauer, A. Gal, T. Brabletz, M. Schreiber, M. Jechlinger, and H. Beug ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells Cancer Cell 10 2006 227 239
119. E. Bertran, L. Caja, E. Navarro, P. Sancho, J. Mainez, M.M. Murillo, A. Vinyals, A. Fabra, and I. Fabregat Role of CXCR4/SDF-1 α in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-β Cell. Signal. 21 2009 1595 1606
120. B. Toh, X. Wang, J. Keeble, W.J. Sim, K. Khoo, W.C. Wong, M. Kato, A. Prevost-Blondel, J.P. Thiery, and J.P. Abastado Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor PLoS Biol. 9 2011 e1001162
121. M. de Graauw, M.H. van Miltenburg, M.K. Schmidt, C. Pont, R. Lalai, J. Kartopawiro, E. Pardali, S.E. Le Devedec, V.T. Smit, A. van der Wal, L.J. Van't Veer, A.M. Cleton-Jansen, P. ten Dijke, and B. van de Water Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells Proc. Natl. Acad. Sci. USA 107 2010 6340 6345
122. M.K. Wendt, M.A. Taylor, B.J. Schiemann, and W.P. Schiemann Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer Mol. Biol. Cell 22 2011 2423 2435
123. S. Giampieri, C. Manning, S. Hooper, L. Jones, C.S. Hill, and E. Sahai Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility Nat. Cell Biol. 11 2009 1287 1296
124. S. Giampieri, S. Pinner, and E. Sahai Intravital imaging illuminates transforming growth factor β signaling switches during metastasis Cancer Res. 70 2010 3435 3439
125. D. Padua, X.H. Zhang, Q. Wang, C. Nadal, W.L. Gerald, R.R. Gomis, and J. Massagué TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4 Cell 133 2008 66 77
126. I. Serganova, E. Moroz, J. Vider, G. Gogiberidze, M. Moroz, N. Pillarsetty, M. Doubrovin, A. Minn, H.T. Thaler, J. Massagué, J. Gelovani, and R. Blasberg Multimodality imaging of TGFβ signaling in breast cancer metastases FASEB J. 23 2009 2662 2672
127. M. Korpal, J. Yan, X. Lu, S. Xu, D.A. Lerit, and Y. Kang Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis Nat. Med. 15 2009 960 966
128. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordon-Cardo, T.A. Guise, and J. Massagué A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
129. Y. Kang, W. He, S. Tulley, G.P. Gupta, I. Serganova, C.R. Chen, K. Manova-Todorova, R. Blasberg, W.L. Gerald, and J. Massagué Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway Proc. Natl. Acad. Sci. USA 102 2005 13909 13914
130. J.M. Yingling, K.L. Blanchard, and J.S. Sawyer Development of TGF-β signalling inhibitors for cancer therapy Nat. Rev. Drug Discov. 3 2004 1011 1022
131. L.J.A.C. Hawinkels, and P. ten Dijke Exploring anti-TGF-β therapies in cancer and fibrosis Growth Factors 29 2011 140 152
132. R.S. Muraoka, N. Dumont, C.A. Ritter, T.C. Dugger, D.M. Brantley, J. Chen, E. Easterly, L.R. Roebuck, S. Ryan, P.J. Gotwals, V. Koteliansky, and C.L. Arteaga Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases J. Clin. Invest. 109 2002 1551 1559
133. Y.A. Yang, O. Dukhanina, B. Tang, M. Mamura, J.J. Letterio, J. MacGregor, S.C. Patel, S. Khozin, Z.Y. Liu, J. Green, M.R. Anver, G. Merlino, and L.M. Wakefield Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects J. Clin. Invest. 109 2002 1607 1615
134. S. Biswas, M. Guix, C. Rinehart, T.C. Dugger, A. Chytil, H.L. Moses, M.L. Freeman, and C.L. Arteaga Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression J. Clin. Invest. 117 2007 1305 1313
135. J.S. Nam, M. Terabe, M. Mamura, M.J. Kang, H. Chae, C. Stuelten, E. Kohn, B. Tang, H. Sabzevari, M.R. Anver, S. Lawrence, D. Danielpour, S. Lonning, J.A. Berzofsky, and L.M. Wakefield An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments Cancer Res. 68 2008 3835 3843
136. A.K. Reka, H. Kurapati, V.R. Narala, G. Bommer, J. Chen, T.J. Standiford, and V.G. Keshamouni Peroxisome proliferator-activated receptor-γ activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition Mol. Cancer Ther. 9 2010 3221 3232
137. S. Doi, Y. Zou, O. Togao, J.V. Pastor, G.B. John, L. Wang, K. Shiizaki, R. Gotschall, S. Schiavi, N. Yorioka, M. Takahashi, D.A. Boothman, and M. Kuro-o Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice J. Biol. Chem. 286 2011 8655 8665
138. D. Melisi, S. Ishiyama, G.M. Sclabas, J.B. Fleming, Q. Xia, G. Tortora, J.L. Abbruzzese, and P.J. Chiao LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis Mol. Cancer Ther. 7 2008 829 840
139. V. Ganapathy, R. Ge, A. Grazioli, W. Xie, W. Banach-Petrosky, Y. Kang, S.
140. E.C. Connolly, E.F. Saunier, D. Quigley, M.T. Luu, A. De Sapio, B. Hann, J.M. Yingling, and R.J. Akhurst Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761 Cancer Res. 71 2011 2339 2349